MatchRX Launches Wholesale Expansion–Helping Pharmacies Slash Drug Costs
ROYAL OAK, Mich., March 27, 2025 /PRNewswire/ -- Independent pharmacies across the country are saving thousands on prescription drugs, thanks...
Day: March 27, 2025
e123 President Brendan McLoughlin to host panel on Medicare market shifts at Medicarians
Discussion will focus on navigating market changes amid Trump administration's Medicare policies LAS VEGAS, March 27, 2025 /PRNewswire/ -- e123 is...
FlyteHealth Executive Board Chair, Dr. Cheryl Pegus, Co-Chair of newly launched Duke-Margolis Health Capital Impact Council
NEW CANAAN, Conn., March 27, 2025 /PRNewswire/ -- Cheryl Pegus, MD, MPH, Executive Board Chair of FlyteHealth, is Co-Chair of...
Wishpond Collaborates with Venops to Transform Professional Medical Engagements with AI-Powered SalesCloser Platform
Wishpond enters into a collaboration agreement with Venops to market and sell Wishpond's AI-powered SalesCloser platform, white-labeled as Provencis, to...
Canada’s Largest Association for Natural, Organic, and Wellness Industry Calls on Party Candidates to Commit to Protecting Canadian Businesses
Ottawa, Ontario--(Newsfile Corp. - March 27, 2025) - On election day, Canadians are voting to protect Canada. Ballots will be...
Safe Supply Streaming Co. Ltd. Announces the Appointment of Tony Clement to Board of Directors, and Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - March 27, 2025) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe...
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
2,000+ Average-Risk Patient Study Seeks to Confirm Mainz Biomed’s Industry-Leading Results in the Detection of Advanced Precancerous Lesions (APL) in...
Digital Utilities Ventures Secures $3.4M Contract to Deploy Easy FEN™ Sustainable Agriculture Units in Africa
Pioneering Green Technology to Transform Food Security and Agricultural ProductivityKey Highlights: Sustainable Agriculture Solution for AfricaDigital Utilities Ventures (DUTV) has...
Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update
-- Company expands commercial product offering with FemBloc® permanent birth control (delivery system) approval in Europe and signed partnerships for...
Alzheimer’s Data Challenge Names Winners for Innovative Biomarker Research Competition
Global Researchers Recognized for Trailblazing Projects in First-of-Its-Kind Data CompetitionWASHINGTON, March 27, 2025 (GLOBE NEWSWIRE) -- International non-profit organization The...
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra
INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts...
Prime Biome: Best Probiotic Supplement? Prime Biome Redefines the Skin-Gut Cell Turnover Approach
Prime Biome is a science-backed probiotic that rejuvenates skin and supports digestion. Learn where to buy Prime Biome gummies.ST. PETERSBURG,...
Premier Health Announces CEO Departure
MONTRÉAL, March 27, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech...
Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress
ONP-002 Advances Toward Phase IIa Concussion Trial with Strengthened Financial Foundation and Industry MomentumSARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE)...
FibroBiologics Announces 2025 Annual Meeting of Stockholders
HOUSTON, March 27, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued...
SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System
The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, India to Aster...
Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers
Reinforces potential of nebokitug to become the first approved drug with disease-modifying activity for PSC--a deadly disorder that currently has...
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
-Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal Cancer-...
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
GARDEN CITY, NY, March 27, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next...
Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting
Studies to assess efficacy, safety, user experience, and nasal residence time as Company prepares for regulatory path forward Raanana, Israel,...